Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 113 Records) |
| Query Trace: Glioma and TERT[original query] |
|---|
| Infrequent RAS mutation is not associated with specific histological phenotype in gliomas. BMC cancer 2021 Sep 21 (1): 1025. Makino Yasuhide, Arakawa Yoshiki, Yoshioka Ema, Shofuda Tomoko, Minamiguchi Sachiko, Kawauchi Takeshi, Tanji Masahiro, Kanematsu Daisuke, Nonaka Masahiro, Okita Yoshiko, Kodama Yoshinori, Mano Masayuki, Hirose Takanori, Mineharu Yohei, Miyamoto Susumu, Kanemura Yonehi |
| TERT Gene rs2736100 and rs2736098 Polymorphisms are Associated with Increased Cancer Risk: A Meta-Analysis. Biochemical genetics 2021 Jun . Zhang Xinyu, Chen Yan, Yan Donglin, Han Jing, Zhu Longbi |
| Comprehensive Molecular Characterization of Chinese Patients with Glioma by Extensive Next-Generation Sequencing Panel Analysis. Cancer management and research 2021 5 13 3573-3588. Zeng Chun, Wang Jing, Li Mingwei, Wang Huina, Lou Feng, Cao Shanbo, Lu Chang |
| TERT Mutation Is Accompanied by Neutrophil Infiltration and Contributes to Poor Survival in Isocitrate Dehydrogenase Wild-Type Glioma. Frontiers in cell and developmental biology 2021 5 9 654407. Gao Mengqi, Lin Yi, Liu Xing, Zhao Zheng, Zhu Zhiyuan, Zhang Hongbo, Ban Yunchao, Bie Yanan, He Xiaozheng, Sun Xiang, Zhang Shizho |
| High prevalence of developmental venous anomaly in adult patients with midline thalamic diffuse gliomas. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2021 4 87 59-65. Zhou Xingwang, Niu Xiaodong, Mao Qing, Liu Yanh |
| Analysis of Mitochondrial DNA Control Region D-Loop in Gliomas: Result of 52 Patients. Turkish neurosurgery 2020 07 . Yuksel Sirin K, Ozduman Koray, Yilmaz Engin, Pamir M Necmettin, Akyerli Cemaliye |
| Genomic Profiling Identified Novel Prognostic Biomarkers in Chinese Midline Glioma Patients. Frontiers in oncology 2020 10 607429. Li Hainan, Shan Changguo, Wu Shengnan, Cheng Baijie, Fan Chongzu, Cai Linbo, Chen Yedan, Shi Yuqian, Liu Kaihua, Shao Yang, Zhu Dan, Li Z |
| Human TERT promoter mutations as a prognostic biomarker in glioma. Journal of cancer research and clinical oncology 2021 2 147 (4): 1007-1017. Powter Branka, Jeffreys Sarah A, Sareen Heena, Cooper Adam, Brungs Daniel, Po Joseph, Roberts Tara, Koh Eng-Siew, Scott Kieran F, Sajinovic Mila, Vessey Joey Y, de Souza Paul, Becker Therese |
| Telomerase reverse transcriptase promoter mutation- and O-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link? European journal of cancer (Oxford, England : 1990) 2021 2 147 84-94. Gramatzki Dorothee, Felsberg Jörg, Hentschel Bettina, Wolter Marietta, Schackert Gabriele, Westphal Manfred, Regli Luca, Thon Niklas, Tatagiba Marcos, Wick Wolfgang, Schlegel Uwe, Krex Dietmar, Matschke Jakob, Roth Patrick, Suresh Marian P, Kamp Marcel A, Rushing Elisabeth J, Pietsch Torsten, von Deimling Andreas, Sabel Michael, Loeffler Markus, Weller Michael, Reifenberger Gui |
| Diffuse Gliomas of the Brainstem and Cerebellum in Adults Show Molecular Heterogeneity. The American journal of surgical pathology 2021 2 45 (8): 1082-1090. Eschbacher Kathryn L, Ida Cristiane M, Johnson Derek R, Alvi Mohammed A, Jenkins Sarah M, Ruff Michael W, Kerezoudis Panagiotis, Neth Bryan J, Pasion Romela M, Daniels David J, Kizilbash Sani H, Raghunathan Adit |
| Clinical and Prognostic Implications of 1p/19q, IDH, BRAF, MGMT Promoter, and TERT Promoter Alterations, and Expression of Ki-67 and p53 in Human Gliomas. Cancer management and research 2021 12 13 8755-8765. Yang Zixi, Ling Feng, Ruan Sibei, Hu Jiajia, Tang Mingxi, Sun Xingwang, Long Wen |
| Prognostic value of preoperative inflammatory markers among different molecular subtypes of lower-grade glioma. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2021 11 96 180-186. Qi Zengxin, Cai Jiajun, Meng Xiangda, Cai Shengyong, Tang Chao, Lang Liq |
| History of atopy confers improved outcomes in IDH mutant and wildtype lower grade gliomas. Journal of neuro-oncology 2021 Oct . Jaman Emade, Zhang Xiaoran, Sandlesh Poorva, Habib Ahmed, Allen Jordan, Saraiya Raj G, Amankulor Nduka M, Zinn Pascal |
| The Place and Prognostic Value of TERT Promoter Mutation in Molecular Classification in Grade II-III Glial Tumors and Primary Glioblastomas. Turk patoloji dergisi 2021 Sep . Terzi Neslihan Kaya, Yilmaz Ismail, Oz Aysim Bu |
| Integrative analysis of CBR1 as a prognostic factor associated with IDH-mutant glioblastoma in the Chinese population. American journal of translational research 2022 9 14 (8): 5394-5408. Ji Pengxiang, Shan Xueshi, Wang Jian, Zhang Ping, Cai Zh |
| A Targeted Next-Generation Sequencing Panel to Genotype Gliomas. Life (Basel, Switzerland) 2022 Jun 12 (7): . Guarnaccia Maria, Guarnaccia Laura, La Cognata Valentina, Navone Stefania Elena, Campanella Rolando, Ampollini Antonella, Locatelli Marco, Miozzo Monica, Marfia Giovanni, Cavallaro Sebastia |
| Telomerase Reverse Transcriptase Promoter Mutations in A Cohort Of Adult Gliomas - Clinicopathological Correlates. Neurology India 0 70 (3): 953-959. Balakumar Shailaja, Pai Rekha, Chacko Ari G, Patel Bimal, Nancy Rachel, Balakrishnan Rajesh, Sarkar Sauradeep, Sampath Gowri, Chacko Gee |
| Cumulative Evidence for Relationships Between Multiple Variants in the TERT and CLPTM1L Region and Risk of Cancer and Non-Cancer Disease. Frontiers in oncology 2022 12 946039. Tian Jie, Wang Yan, Dong Yingxian, Chang Junke, Wu Yongming, Chang Shuai, Che Guow |
| A radiomics feature-based nomogram to predict telomerase reverse transcriptase promoter mutation status and the prognosis of lower-grade gliomas. Clinical radiology 2022 5 77 (8): e560-e567. Lu J, Li X, Li |
| Identification of Four Metabolic Subtypes of Glioma Based on Glycolysis-Cholesterol Synthesis Genes. Computational and mathematical methods in medicine 2022 2022 9448144. Zhang Jinsen, Xiao Xing, Guo Qinglong, Wei Zixuan, Hua W |
| Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations. ESMO open 2022 12 7 (6): 100641. Murugesan K, Necchi A, Burn T C, Gjoerup O, Greenstein R, Krook M, López J A, Montesion M, Nimeiri H, Parikh A R, Roychowdhury S, Schwemmers S, Silverman I M, Vogel |
| Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26. Neuro-oncology 2022 12 . Alpen Karen, Vajdic Claire M, MacInnis Robert J, Milne Roger L, Koh Eng-Siew, Hovey Elizabeth, Harrup Rosemary, Bruinsma Fiona, Nguyen Tuong L, Li Shuai, Joseph David, Benke Geza, Dugué Pierre-Antoine, Southey Melissa C, Giles Graham G, Rosenthal Mark, Drummond Katharine J, Nowak Anna K, Hopper John L, Kapuscinski Miroslaw, Makalic En |
| Epidemiological characteristics and genetic alterations in adult diffuse glioma in East Asian populations. Cancer biology & medicine 2022 11 19 (10): 1440-59. Mo Zongchao, Xin Junyi, Chai Ruichao, Woo Peter Y M, Chan Danny T M, Wang Jigua |
| Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B and RTEL1 genes in glioma: a meta-analysis. Frontiers in oncology 2023 9 13 1180099. Yaqi Wu, Jun Zhou, Jun Zhang, Zhijian Tang, Xi Chen, Lulu Huang, Shengwen Liu, Hong Chen, Yu Wa |
| Association of human telomerase reverse transcriptase promoter mutation with unfavorable prognosis in glioma: A systematic review and meta-analysis. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 2023 7 28 47. Rongxuan Hua, Qiuxuan Li, Han Gao, Boya Wang, Chengwei He, Ying Wang, Sitian Zhang, Lei Gao, Hongwei Shang, Wen Wang, Jingdong |
| Relationship between IDH1/2 and TERT promoter mutation and the prognosis of human glioma patients. Pakistan journal of medical sciences 2023 5 39 (3): 843-847. Xipeng Liu, Ming Liu, Bing Cao, Jianxin Qiao, Xiufeng Zha |
| Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort. Acta neuropathologica communications 2024 7 12 (1): 120. Nobuhide Hayashi, Junya Fukai, Hirokazu Nakatogawa, Hiroshi Kawaji, Ema Yoshioka, Yoshinori Kodama, Kosuke Nakajo, Takehiro Uda, Kentaro Naito, Noriyuki Kijima, Yoshiko Okita, Naoki Kagawa, Yoshinobu Takahashi, Naoya Hashimoto, Hideyuki Arita, Koji Takano, Daisuke Sakamoto, Tomoko Iida, Yoshiki Arakawa, Takeshi Kawauchi, Yukihiko Sonoda, Yuta Mitobe, Kenichi Ishibashi, Masahide Matsuda, Takamune Achiha, Takahiro Tomita, Masahiro Nonaka, Keijiro Hara, Noriyoshi Takebe, Takashi Tsuzuki, Yoshikazu Nakajima, Shiro Ohue, Nobuyuki Nakajima, Akira Watanabe, Akihiro Inoue, Masao Umegaki, Daisuke Kanematsu, Asako Katsuma, Miho Sumida, Tomoko Shofuda, Masayuki Mano, Manabu Kinoshita, Kanji Mori, Naoyuki Nakao, Yonehiro Kanemu |
| Rapid Tumor DNA Analysis of Cerebrospinal Fluid Accelerates Treatment of Central Nervous System Lymphoma. Blood 2024 5 . Mihir Gupta, Joseph Bradley, Elie Massaad, Evan Burns, N Zeke Georgantas, Garrett Maron, Julie Batten, Aidan Gallagher, Julia Thierauf, Naema Nayyar, Amanda Gordon, SooAe Jones, Michelle Pisapia, Ying Sun, Pamela Stuart Jones, Fred G Barker, William Curry, Rajiv Gupta, Javier Romero, Nancy Wang, Priscilla Brastianos, Maria Martinez-Lage, Kensuke Tateishi, Deborah Anne Forst, Brian Vala Nahed, Tracy T Batchelor, Lauren L Ritterhouse, Florian Iser, Tobias Kessler, Justin T Jordan, Jorg Dietrich, Matthew L Meyerson, Daniel P Cahill, Jochen K Lennerz, Bob Carter, Ganesh M Shank |
| Pediatric-type high-grade gliomas with PDGFRA amplification in adult patients with Li-Fraumeni syndrome: clinical and molecular characterization of three cases. Acta neuropathologica communications 2024 4 12 (1): 57. Yuji Kibe, Fumiharu Ohka, Kosuke Aoki, Junya Yamaguchi, Kazuya Motomura, Eiji Ito, Kazuhito Takeuchi, Yuichi Nagata, Satoshi Ito, Nobuhiko Mizutani, Yoshiki Shiba, Sachi Maeda, Tomohide Nishikawa, Hiroki Shimizu, Ryuta Sai |
| TERTp Mutation and its Prognostic Value in Glioma Patients Under the 2021 WHO Classification: A Real-World Study. Cancer medicine 2025 1 14 (2): e70533. Hao Xing, Delin Liu, Junlin Li, Yulu Ge, Xiaopeng Guo, Wenlin Chen, Dachun Zhao, Yixin Shi, Yilin Li, Yaning Wang, Yuekun Wang, Yu Xia, Jiaming Wu, Tingyu Liang, Hai Wang, Qianshu Liu, Shanmu Jin, Tian Qu, Siying Guo, Huanzhang Li, Tianrui Yang, Kun Zhang, Yu Wang, Wenbin |
- Page last reviewed:Feb 1, 2024
- Content source: